Ansgar Eschkötter Joins Senior Management Team of the PS Group
mehr
Ergebnis der Suchanfrage nach Meerbusch
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
5 Treffer
Semdor Pharma adds Global Pharmaceutical Executive Rolf Hoffmann to its Board of Directors
Cologne (ots) - 30-year pharma veteran Rolf Hoffmann, formerly senior global executive at Amgen and Eli Lilly, joins Semdor Pharma as investor and commercial expert. Semdor Pharma Group announced today that it has added Rolf Hoffmann, a seasoned global pharma executive and advisor, to its Board of Directors, as well as an investor in the company. Mr. Hoffmann ...
mehrMerger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
mehrEANS-General Meeting: K+S Aktiengesellschaft / Announcement convening the general meeting
issuer: K+S Aktiengesellschaft Bertha-von-Suttner-Straße 7 D-34131 Kassel phone: +49 (0)561 9301-1460 FAX: +49 (0)561 9301-2425 mail: investor-relations@k-plus-s.com WWW: http://www.k-plus-s.com sector: Chemicals ISIN: DE000KSAG888 indexes: DAX, Midcap Market Index, CDAX, Classic All Share, HDAX, Prime All Share stockmarkets: regulated dealing: Hannover, Berlin, ...
mehreuro adhoc: Marseille-Kliniken AG / Financial Figures/Balance Sheet / - Increase in turnover in the financial year 2007/2008 to EUR 228.1 m - Consolidated net income reaches EUR 1.14 per share - Surge in profits in the Rehabilitation segment
Further inquiry note: Marseille-Kliniken AG Axel Hölzer CEO Alte Jakobstraße 79/80 10709 Berlin Germany Tel.: +49 30 / 246 32-400 Fax: +49 30 / 246 32-401 www.marseille-kliniken.com Hillermann Consulting Christian Hillermann Investor Relations Marseille-Kliniken AG Poststraße 14/16 20354 Hamburg Germany Tel.: ...
mehr
1